Clinical Trial Update: RayGel-An Alternative for Skin Care During External Beam Radiation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating RayGel-An as a skin care agent during external beam radiation for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• RayGel-An

Snippet

Sponsor: Nathalie Johnson | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED